Soleno Therapeutics, Inc.
NASDAQ:SLNO
76.78 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 87.928 | 169.681 | 14.602 | 21.304 | 49.224 | 20.733 | 23.099 | 17.1 | 2.726 | 5.495 | 7.957 | 1.269 | 2.155 |
| Short Term Investments
| 203.509 | 0 | 0 | 0 | 0 | 0 | 0.978 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 291.437 | 169.681 | 14.602 | 21.304 | 49.224 | 20.733 | 24.077 | 17.1 | 2.726 | 5.495 | 7.957 | 1.269 | 2.155 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0.064 | 0 | 0 | 0.156 | 0 | 0.15 | 0.151 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.66 | 0.551 | 0.109 | 0 | 0 |
| Other Current Assets
| 2.452 | 1.677 | 1.045 | 2.236 | 2.038 | 0.822 | 0.529 | 0.894 | 1.075 | 0.203 | 0.272 | 0.105 | 0.082 |
| Total Current Assets
| 293.889 | 171.358 | 15.647 | 22.422 | 50.243 | 21.144 | 24.67 | 17.994 | 3.801 | 6.404 | 8.338 | 1.524 | 2.388 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 2.984 | 0.419 | 0.157 | 0.454 | 0.158 | 0.444 | 0.012 | 0.023 | 0.103 | 0.086 | 0.058 | 0.063 | 0.105 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.126 | 0.718 | 0.718 | 0 | 0 | 0 |
| Intangible Assets
| 6.805 | 8.749 | 10.693 | 12.637 | 14.581 | 16.525 | 18.469 | 20.413 | 0.817 | 0.917 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 6.805 | 8.749 | 10.693 | 12.637 | 14.581 | 16.525 | 18.469 | 20.413 | 1.535 | 1.635 | 0 | 0 | 0 |
| Long Term Investments
| 27.211 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.083 | 0.165 | 0 | 0.04 | 0 | 0.059 | 0 | 0.592 | 0.126 | 0.076 | 0 | 0 | 0.021 |
| Total Non-Current Assets
| 37.083 | 9.333 | 10.85 | 13.131 | 14.739 | 17.028 | 18.481 | 21.028 | 1.764 | 1.797 | 0.058 | 0.063 | 0.127 |
| Total Assets
| 330.972 | 180.691 | 26.497 | 35.553 | 64.982 | 38.172 | 43.151 | 39.022 | 5.565 | 8.201 | 8.396 | 1.587 | 2.514 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 8.882 | 3.149 | 1.777 | 3.254 | 3.489 | 1.995 | 0.934 | 0.633 | 0.411 | 0.495 | 0.987 | 0.058 | 0.22 |
| Short Term Debt
| 0.526 | 0.273 | 0.31 | 0.564 | 0.139 | 0.305 | 0 | 0 | 0 | 0 | 0.102 | 13.992 | 11.132 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 4.148 | 4.794 | 2.282 | 0 | 0 | 0 | 0 | 0 | -13.992 | -11.132 |
| Other Current Liabilities
| 9.339 | 8.083 | 5.226 | 4.189 | 4.99 | 2.664 | 0.943 | 1.1 | 1.297 | 2.697 | 0.201 | 0.129 | 0.191 |
| Total Current Liabilities
| 18.747 | 11.505 | 7.313 | 8.007 | 8.618 | 4.964 | 1.877 | 1.733 | 1.707 | 3.193 | 1.29 | 14.178 | 11.542 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 49.828 | 0.13 | 0 | 0.175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.465 | 1.36 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 17.284 | 11.549 | 8.836 | 9.578 | 10.817 | 18.261 | 10.861 | 10.472 | 0.422 | 1.785 | 17.439 | 23.808 | 23.808 |
| Total Non-Current Liabilities
| 67.112 | 11.679 | 8.836 | 9.753 | 10.817 | 18.261 | 10.861 | 10.754 | 0.422 | 1.785 | 17.439 | 25.273 | 25.168 |
| Total Liabilities
| 85.859 | 23.184 | 16.149 | 17.76 | 19.435 | 23.225 | 12.738 | 12.487 | 2.13 | 4.977 | 18.729 | 39.451 | 36.71 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.273 | 0.025 |
| Common Stock
| 0.046 | 0.032 | 0.008 | 0.08 | 0.08 | 0.045 | 0.032 | 0.019 | 0.017 | 0.014 | 0.007 | 0.001 | 0.001 |
| Retained Earnings
| -452.26 | -276.41 | -237.422 | -213.355 | -182.445 | -157.806 | -127.032 | -113.979 | -98.312 | -86.247 | -70.975 | -57.101 | -53.393 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -0 | 0 | 0 | -0.093 | -0.074 | -0.159 | -0.212 | -0.145 | -0.155 | -0.216 |
| Other Total Stockholders Equity
| 697.327 | 433.885 | 247.762 | 231.068 | 227.912 | 172.708 | 157.413 | 140.495 | 101.744 | 89.456 | 59.778 | 43.199 | 43.222 |
| Total Shareholders Equity
| 245.113 | 157.507 | 10.348 | 17.793 | 45.547 | 14.947 | 30.413 | 26.535 | 3.435 | 3.224 | -10.333 | -37.864 | -34.196 |
| Total Equity
| 245.113 | 157.507 | 10.348 | 17.793 | 45.547 | 14.947 | 30.413 | 26.535 | 3.435 | 3.224 | -10.333 | -37.864 | -34.196 |
| Total Liabilities & Shareholders Equity
| 330.972 | 180.691 | 26.497 | 35.553 | 64.982 | 38.172 | 43.151 | 39.022 | 5.565 | 8.201 | 8.396 | 1.587 | 2.514 |